WHO’s Landmark move: Diabetes drugs added to essential list after Indian advocate’s push
A Pune based patient advocate, Nupur Lalvani stated that the inclusion of rapid-acting insulin analogues and GLP-1 receptor agonists in WHO list of essential medicine will reduce out-of-pocket costs for…